HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$10.03
Day range
$9.78 - $10.99
Year range
$3.51 - $10.99
Market cap
184.54M USD
Avg Volume
608.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 34.08M | 11.58% |
Operating expense | 22.77M | -16.25% |
Net income | -102.20M | -232.03% |
Net profit margin | -299.89 | -197.57% |
Earnings per share | -2.23 | 38.14% |
EBITDA | -17.82M | 42.87% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 63.74M | -41.36% |
Total assets | 108.42M | -34.06% |
Total liabilities | 401.34M | 14.53% |
Total equity | -292.93M | — |
Shares outstanding | 18.34M | — |
Price to book | -0.63 | — |
Return on assets | -43.60% | — |
Return on capital | -652.05% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -102.20M | -232.03% |
Cash from operations | -11.83M | 54.17% |
Cash from investing | 5.00M | -66.21% |
Cash from financing | 29.69M | 4,266.47% |
Net change in cash | 22.87M | 320.89% |
Free cash flow | -11.61M | -62.50% |
About
Founded
2008
Headquarters
Website
Employees
228
